Background Autophagy is an intracellular bulk degradation process induced by cell starvation. Autophagy was recently reported to be induced by various stresses such as hypoxia, ischemia/reperfusion, toxins, and denatured proteins, and to affect cell survival and death. Light chain 3-II (LC3-II) is specifically located on double membrane-bound autophagosomes that envelop disused proteins or organelles. Method Transgenic mice in which green fluorescent protein (GFP) was fused to LC3 (LC3-GFP) were administered cisplatin (20 mg/kg). After euthanasia at times between 0 and 72 h, kidneys were excised for immunohistochemical analyses. Microscopic examinations of the generated NRK-52E cell lines stably transfected with LC3-GFP, and Western blot analyses of NRK-52E cells, were undertaken after cisplatin treatment with or without autophagy inhibitors and beclin 1 small interfering RNA (siRNA). Results Autophagosomes increased in the proximal tubular cells of transgenic mice from 12 h after cisplatin injection (20 mg/kg). The time course for this was faster than those for tubular necrosis and apoptosis. Autophagosomes also increased in NRK-52E cells after cisplatin treatment, with the time course for this being faster than that for apoptosis. When autophagy was suppressed by autophagy inhibitors or beclin 1 siRNA, the level of apoptosis was also suppressed. Conclusion Autophagy occurs in proximal tubular cells after cisplatin treatment and is involved in cell death in renal tubular injury. Our data suggest that autophagy is a kind of cell damage index and that cells with activated autophagy will be scavenged by apoptosis.
Introduction
Eukaryotes have two major systems for degrading proteins: the ubiquitin-proteasome system and autophagy. The ubiquitin-proteasome system degrades short-lived and selective proteins. Autophagy degrades long-lived and nonselective proteins in large amounts and cell organelles. Autophagy is induced by starvation, changes in cell volume, oxidative stress, accumulation of misfolded proteins, hormonal signaling, irradiation, and xenobiotic treatment [1, 2] , and the roles of autophagy have been suggested to include nutrition, recycling of amino acids, purification, and cellular defense against bacteria. Macroautophagy is the most common form of autophagy, progressing through double-membrane autophagosomes. The discovery of autophagy-related proteins in yeast has revealed the existence of an evolutionarily conserved mechanism for the formation of autophagosomes that sequester cytoplasmic material before they fuse with the endo/lysosomal compartment [3, 4] . Light chain 3-II (LC3-II) is specifically located on double membrane-bound autophagosomes that envelop disused proteins or organelles. LC3-II is a good marker for autophagic membranes. Mizushima et al. confirmed that overexpression of a fusion protein between green fluorescent protein and light chain 3 (LC3-GFP) does not affect endogenous autophagy, and generated transgenic mice that systemically expressed this fusion protein (LC3-GFP mouse). Autophagosomes can be recognized as ringshaped structures by fluorescence microscopy. Using these transgenic mice, autophagy in mouse tissues can be directly monitored by simply creating cryosections and subsequent fluorescence microscopy [5] .
In neurodegenerative disorders, autophagy has been shown to contribute to the elimination of accumulated misfolded proteins [1, 2] . Autophagy is induced in variant cancer cells in response to anticancer therapies; in some cases it promotes cell survival and in other cases it induces apoptosis or type 2 programmed cell death [6] [7] [8] . Chronic myocardial ischemia/reperfusion injury induces autophagy increment and apoptosis decrement [9] . Inhibition of autophagy prevents neuron death after hypoxic-ischemic injury in neonatal mice [10] . However, in acute kidney injury (AKI), the association between autophagy and cell death is not obvious.
Cisplatin is a major chemotherapeutic drug against solid tumors. One of the most important side-effects of cisplatin is nephrotoxicity. Cisplatin is freely filtered at the glomerulus and taken up by renal tubular cells. There are many signaling cascades leading from cisplatin administration to AKI, for example, decreasing renal blood flow, levels of free-radical scavengers, regulating expression of genes, and increasing the numbers of inflammatory cells and levels of caspase-dependent apoptosis. Recently, the level of apoptosis was found to be related to the degree of seriousness of AKI [11] .
The purpose of this study was to investigate the roles of autophagy in tubule cells in AKI to identify a procedure that modifies kidney damage. Our results indicated that cisplatin induces autophagy in proximal tubular cells in vivo. Inhibition of autophagy led to downregulation of cisplatin-induced apoptosis in proximal tubular cells in vitro. Autophagy inhibitors may serve as therapeutic targets for the treatment of AKI.
Subjects and methods

Materials
Anti-light chain 3 antibody was purchased from MBL (Nagoya, Japan); anti-aquaporin-1 antibody was purchased from Abcam (Cambridge, MA); anti-cleaved caspase 3 and rapamycin were purchased from Cell Signaling (Danvers, MA); anti-beclin 1 was purchased from BD Bioscience (Franklin Lakes, NJ); Lipofectamine TM 2000 was purchased from Invitrogen (Carlsbad, CA); 3-methyladenine (3-MA) was purchased from Sigma (Saint Louis, MI); [L-3-transethoxycarbonyloxirane-2-carbonyl]-L-leucine (3-methylbutyl) amide (E64d) and isovaleryl-L-Val-L-Val-AHMHA-L-Ala-AHMHA (pepstatin A) were purchased from Peptide Institute, Inc. (Osaka, Japan); Can Get Signal TM was purchased from TOYOBO (Osaka, Japan).
Animal preparation
All experimental procedures were performed according to the guidelines for the care and use of animals established by Tokyo Medical and Dental University. Male transgenic mice that systemically expressed green fluorescent protein fused to light chain 3 (LC3-GFP mice; a kind gift of Noboru Mizushima, Tokyo Medical and Dental University, Japan) [12] aged 21-22 weeks and weighing 35-40 g were used for the experiments. The mice underwent administration of cisplatin (20 mg/kg); the dose of cisplatin was determined on the basis of the results of previous studies in mice [13] . Kidney samples were harvested at the indicated times. The left kidney was perfused with chilled saline and fixed in 4% buffered paraformaldehyde for histological examination.
Cell culture
The NRK-52E cell line was obtained from the American Type Culture Collection (ATCC; Manassas, VA), and cultured in Dulbecco's Modified Eagle's Medium (DMEM) containing 10% fetal bovine serum, 100 U/ml penicillin, and 100 lg/ml streptomycin at 37°C in a 5% CO 2 incubator. In harvesting experiments, the cells were seeded into 10-cm plastic dishes. In fluorescence microscopy experiments, the cells were seeded into 35-mm glassbottomed dishes. The LC3-GFP plasmid (a kind gift of Noboru Mizushima, Tokyo Medical and Dental University, Japan) was transfected by electroporation on the basis of the results of previous studies [14] . NRK-52E cells (1.0 9 10 7 cells) suspended in K-phosphate-buffered saline (PBS) were electroporated (360 V, 960 lFD) using a Gene Pulser (Bio-Rad, New York, NY). After transfection, the cells were cultured in medium containing 1 g/L G418.
Fluorescence microscopy
We used an Olympus IX 81 microscope. We labeled tissues on the basis of the results of previous studies [13] . We used an Annexin V-Cy3 apoptosis detection kit purchased from BioVision Research Products (Mountain View, CA) to detect apoptosis in vitro. We washed cells with PBS once, added 100 ll annexin V-Cy3 in binding buffer (1:100) for 5 min in the dark, washed with PBS once, added 100 ll 2% paraformaldehyde, incubated for 5 min in the dark, washed cells with PBS twice, and observed the cells within about 30 min.
Beclin 1 knockdown using small interfering RNA Beclin 1 small interfering RNA (siRNA) and scrambled siRNA were purchased from Japan Bio Services Co., Ltd. (Saitama, JAPAN) . The siRNA sequence against beclin 1 was GAUUGAAGACACAGGAGGC [15] . The sequence of the scrambled siRNA was UCUGAAGAGGGGAC-CUAUCTT. NRK-52E cells were transfected using Lipofectamine TM 2000. The scrambled siRNA sequence) was used under identical conditions to the beclin 1 siRNA. To determine the efficiency of beclin 1 knockdown, Western blot analyses for beclin 1 were performed.
NRK-52E cells were transfected with 125 nM siRNA for 4 h from 56 h before harvest; after transfection of cells with siRNAs, we changed the medium to DMEM without fetal bovine serum, penicillin, and streptomycin for 4 h. We changed the medium to DMEM containing 10% fetal bovine serum, but without penicillin and streptomycin, 48 h before harvest, and administered 10 lM cisplatin 24 h before harvest.
Western blot analyses
Whole cell lysates were extracted from cultured NRK-52E cells lysed in sodium dodecyl sulfate (SDS) sample buffer using previously described methods [13] . Lysate proteins (60 lg/lane) were separated on SDS-polyacrylamide gels and transferred to Hybond-ECL (GE Healthcare, Chicago, IL). The blots were incubated with the indicated antibodies (from 1:500 to 1:2000 dilution) overnight, followed by incubation with horseradish peroxidase-conjugated secondary antibodies (1:3000 dilution) for 1 h. Membranes were visualized using Western Blue (Promega, San Luis, CA). The intensities of the bands were quantified using Molecular Dynamics ImageQuant software (Sunnyvale, CA). At harvest, the cells were lysed for 30 min on ice in 150 mM NaCl, 15 mM Tris-HCl, 25 mM NaF, and 1 mM Na 3 VO 4 (pH 8.0).
Statistical analyses
All values are expressed as mean ± standard error of the mean (SEM). Statistical comparisons of differences were performed using one-or two-way analysis of variance (ANOVA) combined with the Newman-Keuls post hoc test. P \ 0.05 was considered significant.
Results
Cisplatin induces macroautophagy in proximal tubular cells in vivo
We first examined the conditions required to induce autophagy and where autophagy was induced using generated transgenic mice that systemically expressed a fusion protein between green fluorescent protein and light chain 3 . The numbers of autophagosomes were increased from 12 h, peaked at around 48 h, and decreased after 72 h. Immunohistochemistry for aquaporin-1 (AQP1), a marker of proximal tubular cells, revealed that the numbers of autophagosomes were increased in AQP1-positive cells. The change in the numbers of autophagosomes was not significant in the medulla (Fig. 3) . We also performed immunohistochemistry for cleaved caspase 3, a marker of the early phase of apoptosis. The increase in the numbers of autophagosomes preceded an increase in the amount of cleaved caspase 3 that was observed 24-48 h after cisplatin treatment (Fig. 4) .
Cisplatin induces macroautophagy in cultured proximal tubular cells
Next we used NRK-52E cells, a proximal tubular cell line, to investigate the effects of cisplatin in vitro. Hanks' balanced salt solution treatment as a starvation condition induced an increase in the numbers of autophagosomes in NRK-52E cells stably transfected with a fusion protein between green fluorescent protein and light chain 3 (LC3-GFP NRK cells) (Fig. 5a) , and generation of LC3-II in Western blot analyses of protein from nontransfected NRK-52E cells (Fig. 5b) . Addition of cisplatin to DMEM induced an increase in the numbers of autophagosomes and generation of LC3-II to a similar level as in the starvation condition. These changes preceded positive staining for annexin V and cleaved caspase 3, a marker of the early phase of apoptosis. The generation of LC3-II was increased dose and time dependently up to 48 h (Figs. 6, 7 ).
Cisplatin-induced apoptosis is suppressed by inhibition of macroautophagy in proximal tubular cells
To examine the involvement of autophagy in the apoptotic pathway, we employed chemical inhibitors and a stimulator of autophagy. We used 3-methyladenine (3-MA), which is widely used as an autophagy inhibitor, as an inhibitor of autophagosome formation [16] . We also used inhibitors of lysosomal proteases including [L-3-trans-ethoxycarbonyloxirane-2-carbonyl]-L-leucine (3-methylbutyl) amide (E64d), a calpain inhibitor, and isovaleryl-L-Val-LVal-AHMHA-L-Ala-AHMHA (pepstatin A), a cathespsin D inhibitor [17] . On the other hand, rapamycin was used to induce autophagosome formation [18] .
We treated LC3-GFP NRK cells with these inhibitors and rapamycin at the same time as adding 40 lM cisplatin. Twenty hours after administration, the cisplatin-induced increase in the numbers of autophagosomes was enhanced by rapamycin and E64d/pepstatin A compared with control cells. On the other hand, the cisplatin-induced increase in the numbers of autophagosomes was depressed by 3-MA compared with control cells. Cisplatin-induced apoptosis was observed as annexin V staining, which was enhanced by rapamycin and suppressed by 3-MA and E64d/pepstatin A (Fig. 8) .
Furthermore, we examined generation of LC3-II in NRK-52E cells. Similar to the results of fluorescence microscopy, generation of LC3-II was enhanced by rapamycin and E64d/pepstatin A compared with controls. On the other hand generation of LC3-II was depressed by 3-MA compared with controls. At the same time we performed Western blot analyses of cleaved caspase 3 as a marker of cisplatin-induced apoptosis. Levels of cleaved caspase 3 were not changed by rapamycin, but were significantly depressed by 3-MA and E64d/pepstatin A (Fig. 9b) . In the absence of cisplatin, band intensity of cleaved caspase 3 increased by 3-MA. This increment may reflect cell damage and cell death by 3-MA in this experimental condition.
Cisplatin-induced apoptosis is suppressed by specific inhibition of macroautophagy by beclin 1 siRNA
To more specifically inhibit autophagy, we used beclin 1 small interfering RNA (siRNA). Beclin 1 is the mammalian homolog of Atg6 and forms a complex with class III phosphatidylinositol 3-kinase (PI3 kinase) [19] . Beclin 1 siRNA suppressed the production of beclin 1, and the 10 lM cisplatin-induced enhancement of cleaved caspase 3 levels was suppressed significantly by the beclin 1 siRNA (Fig. 10) . 
Discussion
This is the first study to demonstrate a relationship between macroautophagy and apoptosis in renal tubular cells by fluorescence microscopic examination using the LC3-GFP mouse. We demonstrated the formation of autophagosomes during cisplatin-induced AKI in vivo, and indicated that cisplatin-induced autophagy occurred faster than apoptosis in proximal tubules. The form of LC3 with a glycine residue at the C-terminal end, termed LC3-I, resides in the cytosol. After activation, the final form of LC3 is designated LC3-II, which associates tightly with the autophagosomal membrane [5] . Because autophagosomes are constantly recycled, and thus are transient structures, the lifetime of LC3-II from activation to decomposition is relatively short. The level of LC3-II represents only the autophagic activity at that moment, and does not indicate the quantity of flow through the autophagic pathway. We examined autophagy with or without cisplatin in the presence of E64d and pepstatin A. The numbers of autophagosomes and the amount of LC3-II were increased by cisplatin. We concluded that cisplatin increased flow through the autophagic pathway [5, 17] .
We demonstrated in this paper that inhibition of autophagy suppressed cisplatin-induced apoptosis. Our data clearly showed that autophagy precedes apoptosis, and that inhibition of autophagy using two inhibitors or beclin 1 siRNA suppressed apoptosis. 3-MA is thought to induce its effects via its activity as a class III PI3 kinase inhibitor [16] ; however, it is not only a specific inhibitor of macroautophagy but also has effects on membrane trafficking, alkalinizes the lysosomal lumen, and can inhibit phosphorylation of JNK and p38 [5] . In the absence of cisplatin, band intensity of cleaved caspase 3 increased by 3-MA, as shown in Fig. 9a . This increment may reflect cell damage and cell death by 3-MA, because inhibition of autophagy with 3-MA was reported to sensitize HeLa cells to starvation-induced cell death in some condition [6, 15] . In the presence of cisplatin, levels of cleaved caspase 3 were significantly depressed by 3-MA and E64d/pepstatin A (Fig. 9b) . Thus we believe that inhibition of autophagy downregulates cisplatin-induced apoptosis in proximal tubular cells in vitro, at least in our experimental conditions. Furthermore, we performed experiments with the protease inhibitors E64d and pepstatin A, and with beclin 1 siRNA, obtaining similar results. Why does inhibition of autophagy suppress cisplatininduced apoptosis? There are many possibilities. In a recent in vivo study, Koike et al. indicated that deficiency of Atg7 prevented hippocampal pyramidal neuron death in hippocampi from neonatal mouse brains after hypoxic-ischemic injury [10] . Also, several studies have reported that autophagy and one or more proapoptotic genes (for example, BAX) collaborate to promote cell death [20] [21] [22] . The proapoptotic genes may switch from cell-protective autophagy to injurious autophagy promoting cell death. We will investigate the relationships among autophagy, proapoptotic genes, and apoptosis in future studies. Why does autophagy yield apoptosis? The inhibition of autophagy increases the mutation rate in yeast [23] . In conditions of chronic stress induced by limited resources (for example, starvation, dehydration, and chronic ischemia), scavenging more damaged cells by activating autophagy can reduce the consumption of limited resources. However, if the duration of the stress were short, scavenging might eliminate recoverable cells.
Recently, Yang et al. and Periyasamy-Thandavan et al. indicated that inhibition of cisplatin-induced autophagy enhanced cisplatin-induced apoptosis [24, 25] . Their report was the first report to indicate a relationship between autophagy and apoptosis in kidney cells; however, they did not perform in vivo experiments. 
N.S.
Densitometric analysis of beclin1
Densitometric analysis of cleaved caspase 3 Fig. 10 Cisplatin-induced apoptosis is suppressed by specific inhibition of macroautophagy by beclin 1 siRNA in vitro. a Western blots of protein from NRK-52E cells treated with scrambled siRNA or beclin 1 siRNA. Beclin 1 siRNA suppressed the expression of beclin 1. Graph summaries of Western blots using a densitometer are also shown. Each bar represents the mean ± SEM (n = 4). *P \ 0.01 versus control. b Western blots of protein from NRK-52E cells treated with scrambled siRNA or beclin 1 siRNA with or without 10 lM cisplatin, and graph summaries of Western blots using a densitometer. Each bar represents the mean ± SEM (n = 4). *P \ 0.05 versus control plus cisplatin. The cisplatin-induced enhancement of cleaved caspase 3 was suppressed by beclin 1 siRNA apoptosis show some discrepancy with our results. There are many possible explanations for this discrepancy. One possibility is the difference in cell types, another is the difference in autophagy inhibitors used, and a third possibility is the concentration and timing of siRNAs. Yang et al. used LLC-PK1 cells, and wortmannin, which inhibits class I, II, and III PI3 kinase members nonspecifically and enhances apoptosis through the inhibition of PI3 kinase/ Akt signal transduction cascade, was used to inhibit autophagy [13, 26, 27] . Thus, this discrepancy may indicate the balance between the antiapoptotic effect of the class I PI3 kinase-Akt pathway and apoptotic facilitation of the class III PI3 kinase autophagy pathway. The period during transfection of siRNA and cisplatin administration was different between our study and theirs. The timing of depression of the target protein and the cisplatin-induced apoptosis pathway also might not match. Also, the concentration of siRNA was different between our study and theirs. A high concentration of siRNA might injure cells and induce apoptosis.
A recent report by Suzuki et al. demonstrated an increase in autophagosomes in the renal tubular epithelial cells of ischemic/reperfusion injury in mouse model and in cultured renal tubular cells under hypoxic condition [28] . Our results accord with this study concerning renal tubular injury and autophagy.
In conclusion, our results indicate that cisplatin induces autophagy in proximal tubular cells in vivo, and that inhibition of autophagy downregulates cisplatin-induced apoptosis in proximal tubular cells in vitro. Autophagy inhibitors may serve as therapeutic targets for the treatment of AKI.
